MARZARO, GIOVANNI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.355
AS - Asia 5.864
EU - Europa 2.935
SA - Sud America 925
AF - Africa 866
Continente sconosciuto - Info sul continente non disponibili 141
OC - Oceania 62
Totale 21.148
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.768
SG - Singapore 1.824
CN - Cina 1.170
IT - Italia 946
VN - Vietnam 890
BR - Brasile 566
HK - Hong Kong 498
BD - Bangladesh 235
FI - Finlandia 227
FR - Francia 212
DE - Germania 197
IN - India 175
GB - Regno Unito 162
PL - Polonia 141
CA - Canada 129
SE - Svezia 123
NL - Olanda 110
RU - Federazione Russa 98
IQ - Iraq 97
AR - Argentina 82
JP - Giappone 81
TR - Turchia 63
ZA - Sudafrica 60
ID - Indonesia 55
MX - Messico 55
UA - Ucraina 54
AT - Austria 53
SA - Arabia Saudita 53
EC - Ecuador 50
ES - Italia 48
PK - Pakistan 48
PH - Filippine 46
CH - Svizzera 44
JM - Giamaica 42
VE - Venezuela 40
CO - Colombia 39
IE - Irlanda 37
BJ - Benin 36
KR - Corea 36
NI - Nicaragua 36
MY - Malesia 34
TT - Trinidad e Tobago 34
IL - Israele 33
UZ - Uzbekistan 32
CI - Costa d'Avorio 31
CR - Costa Rica 31
EG - Egitto 31
PY - Paraguay 31
AO - Angola 30
CZ - Repubblica Ceca 30
GR - Grecia 30
HN - Honduras 30
PA - Panama 30
TN - Tunisia 30
IR - Iran 29
UY - Uruguay 29
MD - Moldavia 28
RO - Romania 28
JO - Giordania 27
AE - Emirati Arabi Uniti 26
AZ - Azerbaigian 26
GF - Guiana Francese 26
LY - Libia 26
PS - Palestinian Territory 26
RS - Serbia 26
CV - Capo Verde 25
DZ - Algeria 25
LB - Libano 25
NP - Nepal 25
TH - Thailandia 25
GA - Gabon 24
KE - Kenya 24
PT - Portogallo 24
AL - Albania 23
BE - Belgio 23
EE - Estonia 23
ET - Etiopia 23
GE - Georgia 23
MA - Marocco 23
TJ - Tagikistan 23
BB - Barbados 22
KH - Cambogia 22
MN - Mongolia 22
MU - Mauritius 22
PE - Perù 22
BO - Bolivia 21
LA - Repubblica Popolare Democratica del Laos 21
MR - Mauritania 21
MW - Malawi 21
RW - Ruanda 21
TW - Taiwan 21
AM - Armenia 20
BF - Burkina Faso 20
DO - Repubblica Dominicana 20
LC - Santa Lucia 20
CD - Congo 19
CL - Cile 19
CW - ???statistics.table.value.countryCode.CW??? 19
HR - Croazia 19
HU - Ungheria 19
Totale 20.129
Salva come PNG Salva come JPEG
Città #
Ashburn 1.481
Singapore 1.106
San Jose 1.079
Fairfield 780
Ann Arbor 531
Woodbridge 506
Hong Kong 443
Houston 396
Chandler 374
Beijing 305
Wilmington 290
Cambridge 282
Seattle 260
Ho Chi Minh City 250
Santa Clara 240
Council Bluffs 238
Hanoi 212
Los Angeles 162
Boardman 143
Padova 133
New York 118
Jacksonville 113
Washington 111
Helsinki 108
Princeton 103
Lauterbourg 97
Munich 96
Des Moines 93
Bytom 86
Medford 77
Milan 76
San Diego 69
Dong Ket 67
Dallas 63
Buffalo 62
Da Nang 58
São Paulo 56
Nanjing 54
Tokyo 52
Roxbury 49
Orem 46
Turku 46
Chicago 45
Baghdad 37
Vienna 37
Cotonou 35
Phoenix 35
Managua 33
Rome 33
Brooklyn 32
Abidjan 31
London 31
Shenyang 31
Warsaw 31
Guangzhou 30
Dublin 29
Tashkent 29
Atlanta 27
Luanda 27
The Dalles 27
Baku 26
Panama City 26
Riyadh 26
Kingston 25
Amman 24
Haiphong 24
Libreville 24
Padua 24
San José 24
Stockholm 24
Frankfurt am Main 23
Guayaquil 23
Hefei 23
Montevideo 23
Boston 22
Chennai 22
Dushanbe 22
Montreal 22
Naples 22
Phnom Penh 22
Praia 22
San Francisco 22
Toronto 22
Athens 21
Cape Town 21
Kigali 21
L’Aquila 21
Nouakchott 21
Castries 20
Johannesburg 20
Kuala Lumpur 20
Ulan Bator 20
Bridgetown 19
Hải Dương 19
Rio de Janeiro 19
Addis Ababa 18
Brasília 18
Florence 18
Istanbul 18
Kampala 18
Totale 12.360
Salva come PNG Salva come JPEG
Nome #
A NEW PRODUCTION METHOD OF HIGH SPECIFIC ACTIVITY RADIONUCLIDES TOWARDS INNOVATIVE RADIOPHARMACEUTICALS: THE ISOLPHARM PROJECT 402
The ISOLPHARM project: ISOL-based production of radionuclides for medical applications 337
Preliminary Discovery of Small Molecule Inhibitors of Epidermal Growth Factor Receptor (EGFR) That Bind to the Extracellular Domain 312
Quinazoline-based multi-tyrosine kinase inhibitors: synthesis, modeling, antitumor and antiangiogenic properties 303
Tyrosine kinase inhibitor prodrug-loaded liposomes for controlled release at tumor microenvironment 298
Corilagin Induces High Levels of Apoptosis in the Temozolomide-Resistant T98G Glioma Cell Line 291
Oleocanthalic acid improves MASH features via a NOX1-dependent mechanism 286
Using the TOPS-MODE approach to fit multi-target QSAR models for tyrosine kinases inhibitors 281
Early Evaluation of Copper Radioisotope Production at ISOLPHARM 281
Novel benzoquinoline derivatives via unpredicted condensation of ethyl propiolate and naphthylamines: Synthesis and topoisomerase inhibition activity 269
Targeting kinases with anilinopyrimidines: Discovery of N-phenyl-N'-[4-(pyrimidin-4-ylamino)phenyl]urea derivatives as selective inhibitors of class III receptor tyrosine kinase subfamily 260
Substituted quinazolinones as kinase inhibitors endowed with anti-fibrotic properties 255
Progetto Isolpharm_Ag: produzione di 111Ag e progettazione di radiofarmaci a scopo terapeutico 255
Structural and Functional Insights on an Uncharacterized Aγ-Globin-Gene Polymorphism Present in Four β(0)-Thalassemia Families with High Fetal Hemoglobin Levels 254
Design, synthesis and biological evaluation of novel trimethylangelicin analogues targeting nuclear factor kB (NF-kB) 253
Development of transdermal delivery systems for innovative clinical applications of cannabinoids 252
A new access to quinazolines from simple anilines 251
New Vandetanib analogs: fused tricyclic quinazolines with antiangiogenic potential. 249
Autogrid-based clusterization of kinases: selection of representative conformations for docking purposes 247
Improved Trimethylangelicin Analogs for Cystic Fibrosis: Design, Synthesis and Preliminary Screening 243
A Novel Aza-Derivative Inhibits agr Quorum Sensing Signaling and Synergizes Methicillin-Resistant Staphylococcus aureus to Clindamycin 240
Psoralen Derivatives as Inhibitors of NF-κB/DNA Interaction: Synthesis, Molecular Modeling, 3D-QSAR, and Biological Evaluation 238
Toward novel sulphur-containing derivatives of tetraazacyclododecane: Synthesis, acid-base properties, spectroscopic characterization, DFT calculations, and cadmium(ii) complex formation in aqueous solution 237
The Importance of Descriptor-Based Clusterization in QSAR Models Development: Tyrosine Kinases Inhibitors as a Key Study 237
SAM50, a side door to the mitochondria: The case of cytotoxic proteases 237
A novel phenolic derivative inhibits AHL-dependent Quorum Sensing signaling in Pseudomonas aeruginosa 236
A microwave improvement in the synthesis of the quinazoline scaffold 236
Preliminary Study of a 1,5-Benzodiazepine-Derivative Labelled with Indium-111 for CCK-2 Receptor Targeting 236
Aged Garlic Extract (AGE) and Its Constituent S-Allyl-Cysteine (SAC) Inhibit the Expression of Pro-Inflammatory Genes Induced in Bronchial Epithelial IB3-1 Cells by Exposure to the SARS-CoV-2 Spike Protein and the BNT162b2 Vaccine 234
Benzoquinazoline derivatives as new agents affecting DNA processing. 233
Development and Validation of Novel Z-360-Based Macromolecules for the Active Targeting of CCK2-R 231
Targeting DNA Binding for NF-κB as an Anticancer Approach in Hepatocellular Carcinoma 230
A novel convenient synthesis of benzoquinazolines 229
Psoralenquinones as a Novel Class of Proteasome Inhibitors: Design, Synthesis and Biological Evaluation 229
Preliminary evaluation of the production of non-carrier added 111Ag as core of a therapeutic radiopharmaceutical in the framework of ISOLPHARM_Ag experiment 224
Exploring Epidermal Growth Factor Receptor (EGFR) Inhibitor Features: The Role of Fused Dioxygenated Rings on the Quinazoline Scaffold 221
Third-generation CDK inhibitors: A review on the synthesis and binding modes of Palbociclib, Ribociclib and Abemaciclib 220
Synthesis and antitumor activity of novel amsacrine analogs: the critical role of the acridine moiety in determining their biological activity 213
Quinazoline-based kinase inhibitors: new synthetic approach and biological evaluation. 210
Discovery Of Biarylaminoquinazolines As Novel Tubulin Polymerization Inhibitors 210
Pyrroloquinolinone-based dual topoisomerase I/II inhibitor 202
Photochemical and photobiological studies on furoquinazolines as new psoralen analogs 201
Development of a Novel Furocoumarin Derivative Inhibiting NF-kB Dependent Biological Functions: Design, Synthesis and Biological Effects 200
Furochinazoline come potenziali bioisosteri di furocumarine: sintesi e proprieta’ fotobiologiche 199
Differential Effects of Angelicin Analogues on NF- κ B Activity and IL-8 Gene Expression in Cystic Fibrosis IB3-1 Cells 198
Synthesis of novel psoralen derivatives as inhibitors of NF-kB dependent biological function 197
Molecular mechanism of action of trimethylangelicin derivatives as CFTR modulators 196
Productionvof carrier-free copper radionuclides with the ISOLPHARM method for nuclear medicine 195
Investigational drugs targeting cyclin-dependent kinases for the treatment of cancer: an update on recent findings (2013-2016) 194
6-Arylpyrimidines as novel attractive scaffolds for ATP competitive KSP inhibition 193
4-Anilinoquinazolines endowed with antiangiogenic activity 193
Microwave-promoted mono-N-alkylation of aromatic amines in water: a new efficient and green method for an old and problematic reaction 191
Targeting kinases with anilinopyrimidines: discovery of N-phenyl-N’-[4-(pyrimidin-4-ylamino)phenyl]urea derivatives as selective inhibitors of Type III receptor tyrosine kinase subfamily 191
Photobiological properties of 3-psoralenacetic acids 190
Synthesis and evaluation of erlotinib analogues: exploiting ring closure 188
Biphenylaminoquinazolines as novel dual inhibitors of tyrosine kinases and tubulin polymerization: synthesis, SARs and anticancer properties 188
Psoralen derivatives as NF-kB/DNA interaction inhibitors: structural insight into the binding mode 184
Synthesis and evaluation of tricyclic quinazoline derivatives as egfr inhibitors 183
Known triterpenes and their derivatives as scaffolds for the development of new therapeutic agents for cancer 183
Effects of Sulforaphane on SARS‑CoV‑2 infection and NF‑κB dependent expression of genes involved in the COVID‑19 ‘cytokine storm’ 181
A novel approach to quinazolin-4(3H)-one via quinazoline oxidation: an improved synthesis of 4-anilinoquinazolines 181
Furoquinazolines as furocoumarin analogs: can we improve solubility without impairing biological activity? 181
Psoralen derivatives as inhibitors of NF-κB/DNA interaction: the critical role of the furan ring 181
ETHOSOMAL GEL FORMULATIONS FOR THE TRANSDERMAL DELIVERY OF CANNABINOIDS 181
Quinazoline derivatives as potential anticancer agents: a patent review (2007 – 2010) 180
Surface plasmon resonance based analysis of the binding of LYAR protein to the rs368698783 (G>A) polymorphic Aγ-globin gene sequences mutated in β-thalassemia 179
Deformable Vesicles with Edge Activators for the Transdermal Delivery of Non-Psychoactive Cannabinoids 177
Discovery of Novel Quinazolinone Based mTOR Inhibitors Endowed with Antifibrotic Properties 175
Discovery of novel wtRET and V804MRET inhibitors: from hit to lead 175
Sviluppo di sistemi per la veicolazione transdermica di cannabinoidi 175
Assessing the interaction between hemoglobin and the receptor binding domain of SARS-CoV-2 spike protein through MARTINI coarse-grained molecular dynamics 174
Photobiological properties of 3-psoralenacetic acids 174
Synthesis and Biological Evaluation of Pyrazole-Pyrimidones as a New Class of Correctors of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) 173
Synthesis of small molecule-based ligands for active targeting of CCK2R for the ISOLPHAR-Ag project 173
Sintesi e purificazione dei precursori di desossiCBD per formulazioni innovative per cannabinoidi 172
From single to multi-target kinases inhibitors: using the old-age kinases inhibitors data to face the new-age 172
QSAR and 3D-QSAR Models in the Field of Tubulin Inhibitors as Anticancer Agents 169
Biphenyl tricyclic quinazoline compounds 169
Dual kinase targeting in leukemia 165
New benzoquinazoline derivatives as antitumor agents 163
Chinazoline benzosostituite: sintesi convenzionale vs. sintesi assistita da microonde. 160
Effects of analogues of 4,6,4'-trymethylangelicin on erythroid differentiation and NF-kB activity. 159
VESICULAR TRANSDERMAL DELIVERY SYSTEMS FOR CANNABINOIDS 159
N-acyl-omega-aminoacid ethanolamides resembling anandamide structure: synthesis and biological evaluation. 157
ISOLPHAR_Ag Project:: production and purification of silver ion beams for 111Ag production. 156
FB-Qsar based developement of novel potent Tyrosine-Kinase Inhibitors 154
Discovery of selective, metabolically stable pyrazole-based FLT3 inhibitors for the treatment of acute myeloid leukemia 153
Biological evaluation of psoralen derivatives as inhibitors of NF-kappa B/DNA interaction: molecular modeling, 3D-QSAR, EMSA assays and inhibition of IL-8 gene expression. 151
Lejeuneaceae (Marchantiophyta) from a species-rich taphocoenosis in Miocene Mexican amber, with a review of liverworts fossilised in amber 151
Synthesis and characterization of novel possible bifunctional chelators for Silver-111 in the ISOLPHARM_Ag project 151
Biodistribution Assessment of a Novel 68Ga-Labeled Radiopharmaceutical in a Cancer Overexpressing CCK2R Mouse Model: Conventional and Radiomics Methods for Analysis 149
The Moss Macromitrium Richardii (Orthotrichaceae) with Sporophyte and Calyptra Enclosed in Hymenaea Resin from the Dominican Republic 149
ISOLPHARM_Ag Project: from the production of the the radioisotope 111Ag to the design of a radiopharmaceutical 149
Proteolysis Targeting Chimeric Molecules: Tuning Molecular Strategies for a Clinically Sound Listening 148
Multicomponent Assembly of the Kinesin Spindle Protein Inhibitor CPUYJ039 and Analogues as Antimitotic Agents 148
Inibitori multitirosinchinasi utili per le patologie correlate: modelli farmacoforici, composti identificati tramite questi modelli, metodi per la loro preparazione, la loro formulazione e il loro impiego terapeutico 147
New topoisomerase inhibitors as proapoptotic agents 147
Benzochinazoline: nuovo approccio sintetico 146
Structure-Based Drug Design and Combinatorial Chemistry in the Search of Antimitotic Agents 146
sintesi e studio di polieterocicli azotati ad attività antitumorale 146
Totale 20.522
Salva come PNG Salva come JPEG
Categoria #
all - tutte 58.644
article - articoli 42.198
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 844
selected - selezionate 0
volume - volumi 0
Totale 101.686
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022780 0 0 0 89 80 58 44 113 46 27 73 250
2022/2023920 179 64 17 97 148 140 10 77 100 16 47 25
2023/2024753 31 86 94 57 55 125 44 63 21 34 75 68
2024/20252.499 28 127 119 122 350 62 131 150 242 92 420 656
2025/202610.439 576 784 1.252 1.451 1.091 468 1.370 855 1.058 651 520 363
2026/20271.891 417 410 443 621 0 0 0 0 0 0 0 0
Totale 21.148